| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |